• videocam Live Webinar with Live Q&A
  • calendar_month October 6, 2026 @ 1:00 PM ET/10:00 AM PT
  • signal_cellular_alt Intermediate
  • card_travel Health
  • schedule 90 minutes

FCA Enforcement Trends in Healthcare: Record-Breaking Recoveries and Settlements, Lessons Learned, Mitigating Risks

Targeting Medicare Advantage and Managed Care, Prescription Drugs, Medically Unnecessary Care, Cybersecurity Misrepresentations

Early Bird Pricing!
MSRP
$297.00
$252.45
Save $44.55

Discount expires 9/22/26

This course is $0 with these passes:

CLE
ALL
  1. keyboard_arrow_leftBack

About the Course

Introduction

This CLE webinar will examine recent DOJ False Claims Act (FCA) enforcement activity against healthcare entities that resulted in record-breaking recoveries in FY 2025 totaling more than $5.7 billion. The panel will discuss notable and very costly enforcement actions and settlements, lessons to be learned, and current enforcement trends. The panel will also offer best practices for helping clients mitigate the risk of FCA enforcement action.

Description

Under an administration targeting healthcare fraud, it is not surprising that, of the record $6.8 billion in total FCA settlements and judgments recovered by the DOJ in FY 2025, healthcare-related actions accounted for the majority at over $5.7 billion in recoveries. Enforcement activity focused on Medicare Advantage fraud and managed care issues, prescription drug fraud, allegations of medically unnecessary care, and even cybersecurity misrepresentations.

Notable FCA enforcement actions and settlements included a more than $62 million settlement with Medicare Advantage provider Seoul Medical Group and associated entities for, among other things, submitting false diagnosis codes to increase MA payments; a $45 million settlement with Vohra Wound Physicians for overbilling for wound care services that were either not medically necessary or had not been performed; and a $9.8 million settlement against medical device manufacturer Illumina Inc. for failing to incorporate adequate cybersecurity in its software design and development.

Counsel and healthcare clients should understand DOJ enforcement focus, lessons to be learned from this historic FCA enforcement activity, and potential FCA enforcement trends.

Listen as our expert panel provides an update on FCA enforcement activity in the healthcare industry. The panel will examine key enforcement actions and settlements, review areas on which DOJ is currently focusing, and offer best practices for mitigating the risk of enforcement action.

Presented By

Jonathan A. Porter
Partner
Husch Blackwell LLP

Mr. Porter focuses on white collar criminal defense, federal investigations brought under the False Claims Act, and litigation against the government and whistleblowers, with an emphasis on matters within the healthcare industry. As a former federal prosecutor with the DOJ, he was a key member of multiple international healthcare fraud takedowns and prosecuted a series of high-profile financial crime cases. Mr. Porter also handled major civil investigations and litigation against companies and individuals under the False Claims Act, resulting in record-breaking settlements and judgments. He now uses that experience to guide clients through federal investigations of all kinds, to litigate cases against and involving the government, and to run effective and right-sized internal investigations for corporations. Many of Mr. Porter’s clients are in the healthcare industry, including health systems, physician groups, and other healthcare companies, along with medical professionals and executives. He serves as a vice chair of the American Health Law Association’s Fraud and Abuse Practice Group.

expand_circle_down Expand to View Full Bio expand_circle_up Collapse Bio
Credit Information

  • This 90-minute webinar is eligible in most states for 1.5 CLE credits.


  • Live Online


    On Demand

Date + Time

  • event

    Tuesday, October 6, 2026

  • schedule

    1:00 PM ET/10:00 AM PT

I. Introduction 

A. Trump administration targets healthcare fraud

II. DOJ's record 2025 FY FCA recovery: healthcare focus

A. Medicare Advantage and managed care

B. Prescription drugs

C. Medically unnecessary care

D. Cybersecurity and digital health

III. Notable enforcement actions and settlements

A. Lessons to be learned

IV. Best practices for mitigating risk of enforcement action

V. Key takeaways

The panel will review these and other important considerations:

  • Why was FY 2025 a record-breaking year in FCA recoveries against healthcare entities? In what areas did DOJ focus its enforcement activity?
  • What lessons may be learned from notable settlements?
  • What are current trends and developments in DOJ FCA enforcement?
  • What are best practices for mitigating the risk of enforcement action?